摘要
背景:Thymoquinone(TQ)是一种生物活性植物成分,由黑种(Nigella sativa)(黑种子)获得。它在预防癌症方面具有潜力。 目的:以前的研究表明,TQ可以调节负责癌症进展的信号通路,从而提高临床使用的抗癌药物的功效和改善安全性。 方法:TQ作用于细胞周期,通过靶向各种蛋白质(细胞周期蛋白D1,细胞周期蛋白E和p27)抑制从G1向S期的进展。它还表现出组蛋白去乙酰化酶(HDAC)抑制作用,靶向p21和Maspin,并诱导促凋亡基因Bax和下调抗凋亡基因Bcl-2。据报道,乳腺癌(BC)是妇女最常见的恶性肿瘤之一。结果:尽管研究和进步,它仍然是女性癌症相关死亡的最常见原因之一。 BC的分子筛选的最新进展导致鉴定三阴性乳腺癌(TNBC)的临床挑战性状况。 TNBC的特征是缺乏可靶向的受体,雌激素受体(ER),孕激素受体(PR)和人表皮生长因子受体2(HER2)的表达。其特征还在于磷酸酶和张力蛋白同系物(PTEN)表达的减少或缺失,所述肿瘤抑制基因具有调节细胞凋亡,细胞周期和转移的多种功能。 结论:由于已有报道TQ能够上调血管内皮生长因子(VEGF),EGF和PTEN表达等多种生长因子,因此本文综述了TQ对这类乳腺癌治疗干预的靶向潜能。
关键词: Thymoquinone,黑种子,HDAC,乳腺癌,TNBC,凋亡,VEGF。
Current Drug Targets
Title:Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer
Volume: 19 Issue: 1
关键词: Thymoquinone,黑种子,HDAC,乳腺癌,TNBC,凋亡,VEGF。
摘要: Background: Thymoquinone (TQ) is a bioactive phytoconstituent obtained from Nigella sativa (black seeds). It has promising potential in cancer prevention.
Objective: Previous studies have shown that TQ can modulate signaling pathways responsible for cancer progression, thus enhancing the efficacy and improving the safety profile of clinically used anticancer drugs.
Method: TQ acts on cell cycle and inhibits progression from G1 to S phase by targeting various proteins (cyclin D1, cyclin E, and p27). It also exhibits histone deacetylase (HDAC) inhibitory effects, targets p21 and Maspin, and induces pro-apoptotic gene, Bax and downregulates anti-apoptotic gene Bcl-2. Breast cancer (BC) is reported as one of the most common malignancies in women.
Results: Despite the research and advancement, it remains one of the most common causes of cancer related deaths among women. Recent advancements in molecular screening of BC led to the identification of clinically challenging condition of triple negative breast cancer (TNBC). TNBC is characterized by the absence of targetable receptors viz. estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expressions. It is also characterized by reduced or absence of phosphatase and tensin homolog (PTEN) expression, a tumor suppressor gene having diverse functions including regulation of apoptosis, cell cycle, and metastasis.
Conclusion: Since TQ has been reported to up-regulate several growth factors such as vascular endothelial growth factor (VEGF), EGF and PTEN expression, the present review article discusses the targeting potential of TQ for therapeutic intervention against such types of breast cancer.
Export Options
About this article
Cite this article as:
Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer, Current Drug Targets 2018; 19 (1) . https://dx.doi.org/10.2174/1389450118666170612095959
DOI https://dx.doi.org/10.2174/1389450118666170612095959 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Treatments for COPD in the Elderly
Current Pharmaceutical Design Enteric Coated Guar Gum Microspheres of Ornidazole for Colonic Delivery
Current Nanoscience Mechlorethamine based Drug Structures for Intervention of Central Nervous System Tumors
Central Nervous System Agents in Medicinal Chemistry Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer
Current Cancer Drug Targets Unleashing Breast Cancer Progression: miR-455-5p's Targeting of SOCS3 Drives Proliferation, Migration, and Invasion
Protein & Peptide Letters Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours
Anti-Cancer Agents in Medicinal Chemistry Automated Detection of Breast Tumor in Different Imaging Modalities: A Review
Current Medical Imaging Membrane Disrupting Lytic Peptides for Cancer Treatments
Current Pharmaceutical Design Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets Myeloid Derived Suppressor Cells and Their Role in Diseases
Current Medicinal Chemistry Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets Pharmacological Approaches to Chronic Spinal Cord Injury
Current Pharmaceutical Design Erythropoietin: New Approaches to Improved Molecular Designs and Therapeutic Alternatives
Current Pharmaceutical Design Protein Degradation Pathways after Brain Ischemia
Current Drug Targets Development of Highly Efficient KinExA Immunosensor-Based Assay for the Measurement of Carcinoembryonic Antigen in Serum
Current Analytical Chemistry Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial
Current Radiopharmaceuticals Small Molecule Inhibitors of the XIAP Protein-Protein Interaction
Current Topics in Medicinal Chemistry Hypersensitivity to Antineoplastic Agents
Current Pharmaceutical Design Current Drug Targets and Future Therapy of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Psychological Sequelae of Ovarian Cancer Screening and Genetic Testing for Ovarian Cancer Susceptibility
Current Women`s Health Reviews